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Purpose: The purpose of this study was to evaluate the diagnostic performance of S-Detect when 
applied to breast ultrasonography (US), and the agreement with an experienced radiologist 
specializing in breast imaging.
Methods: From June to August 2015, 192 breast masses in 175 women were included. US 
features of the breast masses were retrospectively analyzed by a radiologist who specializes 
in breast imaging and S-Detect, according to the fourth edition of the American College of 
Radiology Breast Imaging Reporting and Data System lexicon and final assessment categories. 
Final assessments from S-Detect were in dichotomized form: possibly benign and possibly 
malignant. Kappa statistics were used to analyze the agreement between the radiologist and 
S-Detect. Diagnostic performance of the radiologist and S-Detect was calculated, including 
sensitivity, specificity, positive predictive value (PPV), negative predictive value, accuracy, and 
area under the receiving operator characteristics curve. 
Results: Of the 192 breast masses, 72 (37.5%) were malignant, and 120 (62.5%) were benign. 
Benign masses among category 4a had higher rates of possibly benign assessment on S-Detect 
for the radiologist, 63.5% to 36.5%, respectively (P=0.797). When the cutoff was set at 
category 4a, the specificity, PPV, and accuracy was significantly higher in S-Detect compared to 
the radiologist (all P<0.05), with a higher area under the receiver operator characteristics curve 
of 0.725 compared to 0.653 (P=0.038). Moderate agreement (k=0.58) was seen in the final 
assessment between the radiologist and S-Detect. 
Conclusion: S-Detect may be used as an additional diagnostic tool to improve the specificity of 
breast US in clinical practice, and guide in decision making for breast masses detected on US.
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Introduction
Ever since the release of the American College of Radiology Breast 
Imaging Reporting and Data System (ACR BI-RADS) lexicon for 
ultrasonography (US) in 2003, studies have proven it to have 
excellent diagnostic performance for breast masses, and it has 
been universally applied to daily practice [1-4]. In addition to the 
differential diagnosis of breast masses, US BI-RADS has contributed 
to standardization of imaging reports and patient management. 
However, many US descriptors are used for describing a breast 
lesion, with each descriptor containing different predictability 
for malignancy, and a consensus has not been reached on which 
descriptors have more significance in predicting malignancy [5]. 
In addition, US has an inherent limitation of interobserver and 
intraobserver variability that leads to differences among operators in 
both image acquisition and interpretation.
As a way to overcome the complexity of applying US descriptors 
and the interobserver variability of breast US, a recent study has 
applied computer-aided diagnosis to breast US for assistance in 
either lesion detection or the decision-making process during 
practice [6]. It has been reported that the diagnostic performance 
of radiologists can be improved by proper application of these 
computer-aided programs [7]. S-Detect is a recently developed 
image-analytic program that provides assistance in morphologic 
analysis of breast masses seen on breast US according to the US 
BI-RADS descriptors and final assessment. This program can guide 
in deciding upon the next management for the patient, which is 
expected to be helpful in everyday practice. To the present, there are 
no studies evaluating the diagnostic performance or the degree of 
agreement of S-Detect with radiologists who are dedicated to breast 
imaging. 
Therefore, the purpose of this study was to evaluate the 
diagnostic performance of S-Detect when applied to breast US, and 
determine the degree of agreement with an experienced radiologist 
specializing in breast imaging. 
Materials and Methods
This study was of a prospective design and was approved by the 
Institutional Review Board of Severance Hospital, Seoul, Korea. 
Informed consent was obtained from all patients for study inclusion. 
Patients 
A total of 181 consecutive women with 201 breast masses who 
were scheduled for breast US examinations, US-guided core needle 
biopsy, or surgical excision from June to August 2015 gave consent 
to be included in this study. Among them, six women were excluded 
because they had non-mass lesions in the breast detected on US, 
since image analysis of these non-mass lesions was difficult to fit 
in the US BI-RADS lexicon, which is mostly intended for localized 
breast masses. Ultimately, 192 breast masses in 175 women were 
included in this study. The mean age of the women was 46.6±13.3 
years (range, 18 to 81 years). The mean size of the breast masses 
included was 14.7±9.7 mm (range, 5 to 52 mm). Of the 192 breast 
masses, 77 (40.1%) were palpable, and one (0.5%) presented with 
bloody nipple discharge. 
US Examination and Biopsy 
US examinations were performed using a 3-12-MHz linear 
transducer (RS80A with Prestige, Samsung Medison, Co. Ltd., Seoul, 
Korea). Two staff radiologists (J.H.Y. and E.-K.K.) with 7 and 19 years 
of experience in breast imaging were involved in image acquisition. 
Both radiologists were aware of the clinical and mammographic 
features and had access to the prior US examinations before US 
examination. Bilateral whole breast examinations were routinely 
performed. When a breast mass was detected, routine scanning 
protocols included transverse and longitudinal scanning of the 
breast mass, still-images recorded with and without calipers used 
for size measurements. For image analysis using S-Detect, video 
clips were recorded with the US machine, including the entire mass 
and surrounding normal breast parenchyma during one-directional 
movement of the probe, starting at one end and ending at the 
other end of the mass. US-guided biopsy was performed after US 
examinations by the same radiologist who had performed breast US. 
Image Review and Application of S-Detect
US features of the breast masses were retrospectively analyzed 
by one staff radiologist (J.H.Y.) who has 7 years of experience in 
breast imaging, following the fourth edition of ACR BI-RADS lexicon 
and final assessment categories: shape, margin, echo pattern, 
orientation, lesion boundary, and posterior features [4]. US features 
regarding calcification were not analyzed due to the limited data 
analytical ability of S-Detect. The radiologist chose and recorded the 
most appropriate term for each descriptor. Final assessments were 
made for each breast mass using one of the assessment categories 
of BI-RADS: category 2, benign; 3, probably benign; 4a, low 
suspicion for malignancy; 4b, intermediate suspicion for malignancy; 
4c, moderate concern for malignancy; and 5, highly suggesting 
malignancy.
For data acquisition from S-Detect, the same radiologist who had 
reviewed the sonograms for analysis retrospectively applied S-detect 
to the same image used for grayscale US feature analysis to each 
breast mass. A region-of-interest (ROI) was drawn along the border 
of the mass (Fig. 1), either automatically by the US unit or manually 
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when the boundary that was automatically drawn by S-Detect was 
considered insufficient by the radiologist. US features according to 
the US BI-RADS lexicon and final assessments were automatically 
analyzed and visualized by S-Detect, which was recorded for data 
analysis. Final assessments from S-Detect were in dichotomized 
form: possibly benign and possibly malignant. 
S-Detect applies a novel feature extraction technique and support 
vector machine classifier that classifies breast masses into benign 
or malignant according to the proposed feature combinations 
integrated according to the US BI-RADS [8]. Features used for US 
feature analysis in S-Detect are as follows: shape differences, echo 
and texture features using spatial grey-level dependence matrices, 
intensity in the mass area, gradient magnitude in the mass area, 
orientation, depth-width ratio, distance between mass shape and 
best fit ellipse, average gray changes or histogram changes between 
tissue/mass area, comparison of gray value of left, posterior, and 
right under the lesion, the number of lobulated areas/protuberances/
depressions, lobulation index, and elliptic-normalized circumference 
[8]. 
Data and Statistical Analyses
Histopathology results from US-guided core needle biopsy, vacuum-
assisted excision, or surgery was considered to be the standard 
reference. For high-risk breast lesions, including atypical ductal 
hyperplasia, atypical lobular hyperplasia, lobular carcinoma in 
situ, intraductal papilloma, mucocele-like lesion, or radial scar, 
final pathological diagnosis of surgery was used. Final pathologic 
diagnosis of high-risk lesions was considered benign for statistical 
analysis. 
The final assessment data given by S-Detect were in dichotomized 
form, possibly benign and possibly malignant, and for statistical 
analysis the final assessments made by the radiologist were 
dichotomized in two ways: (1) cutoff set at category 4a: negative 
(possibly benign), consisting of masses of category 2 and 3, positive 
(possibly malignant), consisting of categories 4a to 5; and (2) cutoff 
set at category 4b: negative consisting of category 2, 3, and 4a, and 
positive consisting of categories 4b to 5. Kappa statistics were used 
to analyze the agreement for US descriptors and final assessment 
between the radiologist and S-Detect. Estimation of the overall 
kappa was based on the study of Landis and Koch [9]: a kappa value 
of less than 0 indicates poor agreement. Kappa values less than 
or equal to 0.20 are considered slight agreement; values of 0.21-
0.40 are considered fair agreement; values of 0.41-0.60, moderate 
agreement; values of 0.61-0.80, substantial agreement; and values 
of 0.81-1.00, almost perfect agreement [9]. Diagnostic performance 
of the radiologist and S-Detect was calculated, including sensitivity, 
specificity, positive predictive value (PPV), negative predictive value 
(NPV), and accuracy, and compared using the generalized estimating 
equation method. Area under the receiver operator characteristics 
curve (AUC) was obtained and compared by Delong’s method. 
Statistical analyses was performed using SAS ver. 9.2 (SAS Inc., 
Cary, NC, USA). All tests were two-sided, and P-values of less than 
0.05 were considered to indicate statistical significance.
Results
Among the 192 breast masses, 72 (37.5%) were malignant, 
and 120 (62.5%) were benign. Fifty-three (27.6%) lesions were 
diagnosed with surgery, eight (4.2%) with vacuum-assisted excision, 
and 118 (61.5%) with US-guided core needle biopsy. Thirteen 
lesions (6.7%) were included based on prior benign biopsy results 
and stability for more than 24 months (n=8) or typically benign US 
phenomena such as cysts (n=5).
Histopathologic diagnoses are shown in Table 1. The mean size 
of malignant masses was significantly larger than that of benign 
masses, 19.7±11.5 mm and 11.9±6.9 mm, respectively (P<0.001). 
Table 2 summarizes the proportion of S-Detect categories among 
each BI-RADS final assessment by the radiologist. Malignant masses 
had higher rates of possibly malignant assessment on S-Detect in 
categories 4a to 4c, but without statistical significance (all P>0.05). 
Benign masses among category 4a had higher rates of probably 
benign assessment on S-Detect, 63.5% to 36.5%, respectively. 
Diagnostic Performance of the Radiologist and S-Detect
Diagnostic performance of the radiologist and S-Detect is 
Fig. 1. Representative image showing the setting of the region-of-
interest (ROI) for S-Detect analysis. After the ROI was drawn along 
the border of the mass, ultrasonographic features were analyzed 
automatically by the S-Detect program and a final assessment was 
produced.
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summarized in Table 3. When the cutoff was set at category 4a for 
the radiologist, sensitivity (100.0% to 79.2%) and NPV (100.0% 
to 84.0%) were significantly higher for the radiologist than for 
S-Detect (all P<0.05). On the other hand, specificity (65.8% to 
30.9%), PPV (58.3% to 46.2%), and accuracy (70.8% to 56.2%) 
were significantly higher for S-Detect than the radiologist (all 
P<0.05, respectively). When the cutoff was set at category 4b 
for the radiologist, specificity (93.3% to 65.8%), PPV (87.3% to 
58.3%), and accuracy (87.0% to 70.8%) were significantly higher 
for the radiologist than for S-Detect (all P<0.05, respectively). AUC 
was significantly higher for S-Detect than the radiologist when the 
cutoff was set at category 4a, 0.725 to 0.653 (P=0.038), but did 
not show significant differences when the cutoff was set at category 
4b (P=0.775) (Fig. 2).
Interobserver Agreement for US Descriptors and Final 
Assessment 
Agreement between the radiologist and S-Detect using US 
descriptors for breast masses is summarized in Table 4: agreement 
was substantial for shape (k=0.64) and orientation (k=0.61), and 
fair for margin (k=0.30), echo pattern (k=0.34), lesion boundary 
(k=0.26), and posterior features (k=0.29). Moderate agreement 
(k=0.58) was seen between the radiologist and S-Detect in the 
dichotomized final assessment. 
Table 2. Distribution of final assessments of the 192 breast masses according to the radiologist and S-Detect
Radiologist Pathology
S-Detect
P-value
Possibly benign Possibly malignant Total 
Category 2 10 (5.2) -
Benign 7 (70.0) 3 (30.0)
Malignancy 0 0 
Category 3 26 (13.5) -
Benign 18 (69.2) 8 (30.8)
Malignancy 0 0 
Category 4a 89 (46.4) 0.797
Benign 47 (63.5) 27 (36.5)
Malignancy 9 (60.0) 6 (40.0)
Category 4b 11 (5.8) 0.953
Benign 5 (71.4) 2 (28.6)
Malignancy 2 (50.0) 2 (50.0)
Category 4c 19 (9.9) 0.310
Benign 2 (66.7) 1 (33.3)
Malignancy 3 (18.7) 13 (81.3)
Category 5 37 (19.2) -
Benign 0 0 
Malignancy 1 (2.7) 36 (97.3)
Values are presented as number (%).
Table 1. Pathologic diagnosis of the 192 breast masses included 
Diagnosis Pathology No. (%)
Benign (n=120) Atypical ductal hyperplasia 3 (2.5)
Apocrine metaplasia 7 (5.8)
Benign phyllodes tumor 1 (0.8)
Cysta) 6 (5.0)
Fibroadenoma 46 (38.3)
Fibroadenomatoid hyperplasia 16 (13.3)
Fibrocystic change 3 (2.5)
Fat necrosis 4 (3.3)
Inflammation 5 (4.2)
Intraductal papilloma 7 (5.8)
Mucocele-like lesion 1 (0.8)
Radial scar 3 (2.5)
Sclerosing adenosis 8 (6.7)
Stability for more than 24 months 8 (6.7)
Stromal fibrosis 2 (1.7)
Malignant (n=72) Ductal carcinoma in situ 7 (9.7)
Invasive ductal carcinoma 56 (77.8)
Invasive lobular carcinoma 2 (2.8)
Medullary carcinoma 1 (1.4)
Mucinous carcinoma 3 (4.2)
Tubular carcinoma 3 (4.2)
a)Including five cysts diagnosed based on typical ultrasonographic features, without 
biopsy.
Application of S-Detect to breast masses
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Discussion
US BI-RADS has contributed greatly to improving communication 
between physicians and radiologists, but still, observer variability 
acts as a major limitation of US, which is considered problematic 
considering the wide application of breast US. As technology has 
evolved, many adjunctive tools for breast US have been developed 
that may aid image interpretation and decision making based on 
this interpretation, including elastography [10] or computer-aided 
diagnosis or detection [11-13]. In this study, we have evaluated 
the diagnostic performance of a computer-aided diagnosis program, 
Table 3. Diagnostic performance of the radiologist and S-Detect
Variable S-Detect Radiologista) P-value Radiologistb) P-value
Sensitivity (%) 79.2 100.0 <0.001 76.4 0.824
Specificity (%) 65.8 30.9 <0.001 93.3 <0.001
PPV (%) 58.3 46.2 0.002 87.3 <0.001
NPV (%) 84.0 100.0 0.005 86.8 0.873
Accuracy 70.8 56.2 0.002 87.0 0.001
AUC (95% CI, %) 0.725
(0.661-0.789)
0.653
(0.603-0.688)
0.038 0.772
(0.706-0.830)
0.775
PPV, positive predictive value; NPV, negative predictive value; AUC, area under the receiver operating characteristics curve; CI, confidence interval; US, ultrasonography; BI-
RADS, Breast Imaging Reporting and Data System.
a)US BI-RADS category 2-3 considered negative, categories 4a-5 considered positive. b)US BI-RADS category 2-4a considered negative, categories 4b-5 considered positive.
Table 4. Agreement on US descriptors and final assessment 
between the radiologist and S-Detect
US feature
ĸ value (95% CI)
Radiologist vs. S-Detect
Shape Oval 0.64 (0.54-0.73)
Round
Lobular 
Irregular
Margin Circumscribed 0.30 (0.20-0.40)
Indistinct
Angular 
Microlobulated
Spiculated
Echo pattern Anechoic 0.34 (0.18-0.49)
Hyperechoic
Isoechoic
Hypoechoic
Complex
Orientation Parallel 0.61 (0.49-0.73)
Not parallel
Lesion boundary Abrupt interface 0.26 (0.11-0.41)
Echogenic halo
Posterior features Absent 0.29 (0.16-0.41)
Enhancement
Shadowing
Combined 
Final assessment Possibly benign 0.58 (0.47-0.69)
Possibly malignant
US, ultrasonography; CI, confidence interval.
Fig. 2. Receiver operator characteristic (ROC) curve for the 
radiologist and S-Detect. Solid blue line, brown interrupted line, 
and orange interrupted line indicates area under the ROC curve 
of radiologist with cutoff at ultrasonography (US) Breast Imaging 
Reporting and Data System (BI-RADS) category 4a (0.653), 
performance of radiologist with cutoff set at US BI-RADS category 
4b (0.772), and area under the ROC curve of S-Detect (0.725), 
respectively.
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S-Detect, in the differential diagnosis of breast masses seen on US. 
S-Detect had significantly higher specificity, PPV, and accuracy 
than a radiologist, as well as a higher AUC (all P<0.05), when 
the cutoff was set at category 4a for the radiologist. In addition, 
malignant masses among category 4a to 4c had higher rates of 
possibly malignant assessment while benign masses in category 
4a had higher rates of probably benign assessment on S-Detect, 
although without statistical significance. Approximately 90% of 
category 4a masses are eventually proven to be benign, and when 
applying S-Detect to category 4a lesions, 52.8% (47 of 89) of the 
benign masses may have avoided invasive biopsy procedures. But 
in contrast, nine of the 56 category 4a lesions assessed as possibly 
benign on S-Detect were confirmed as malignant. S-Detect may 
enable improvement of the specificity of US, but as seen in our 
results, this carries with it a decrease in sensitivity, which must be 
taken into consideration when applying S-Detect in clinical practice. 
Due to this tradeoff, S-Detect should be considered an adjunct to 
breast US, not one to replace grayscale US assessment. 
As mentioned above, the majority of category 4a masses are 
eventually provenbenign, which considerably affects the diagnostic 
performance of the radiologist if the cutoff for dichotomization of 
final assessment categories is set at category 4a. With this in mind, 
the diagnostic performance of the radiologist with the cutoff set 
at category 4b was calculated and compared to the performance 
of S-Detect. With the cutoff at category 4b, the radiologist had 
significantly higher specificity, PPV, accuracy, and AUC compared to 
S-Detect (all P<0.05). Since the present form of S-Detect provides 
dichotomized data, the BI-RADS final assessment categories of 
the radiologist also had been dichotomized for comparison, which 
was significantly affected by the cutoff level set for analysis of our 
results. As biopsy is recommended for breast masses assessed as 
category 4a or higher in clinical practice, diagnostic performance 
of the radiologist with the cutoff set at category 4a may be more 
representative for everyday clinical practice, where S-Detect can be 
considered to provide additional information regarding differential 
diagnosis for breast masses, serving as a second opinion provider 
during practice. 
Kappa values for each BI-RADS US lexicon descriptor and final 
assessment between radiologists has been reported to show fair 
or moderate agreement (0.24-0.41) in the literature [2,14,15]. 
Fair to substantial agreement was seen for US descriptors between 
the radiologist and S-Detect ranging from 0.29 to 0.64. Moderate 
agreement was observed for shape and orientation, consistent 
with previous reports on observer agreement between radiologists 
[2,15], while agreement for margin and lesion boundary was fair, 
k=0.30 and k=0.26, respectively, lower than the agreements of 
the previous reports. Differences in agreement between the prior 
reports and our study reflect the analytic algorithm used in S-Detect 
for image interpretation. For instance, the average grayscale 
differences between tissue/mass area or between posterior/mass 
area were used for analysis, which may explain the fair agreement 
regarding margin and lesion boundary. But more importantly, 
moderate agreement, k=0.58, was seen for the dichotomized final 
assessment showing that the decision making of S-Detect for a 
breast mass detected on US was quite similar to that of a dedicated 
breast radiologist, supporting its potential in providing guidance to 
radiologists with less experience in breast imaging. Further studies 
with a larger number of cases are anticipated to evaluate the most 
effective algorithm for computer-aided diagnosis in breast US. 
There are several limitations to this study. First, the analysis of US 
features was based on the fourth edition of the BI-RADS lexicon, 
since S-Detect implemented the descriptors of the fourth edition in 
its analysis. Although little has changed between the fourth and fifth 
edition of BI-RADS, changes in details may have resulted in different 
results. Second, analysis of calcifications, which is an important 
clue in the diagnosis of breast cancer [16], was not performed with 
S-Detect. Third, non-mass lesions were excluded from the study 
population since analysis was limited for non-mass lesions using 
S-detect. Finally, one radiologist selected the representative image 
and confirmed or drew a ROI for S-Detect analysis, which could have 
differed if other radiologists had been included. The results of our 
study may also have differed if radiologists with different degrees 
of experience had been involved in review and analysis of the 
sonograms. 
In conclusion, S-Detect may be used as an additional diagnostic 
tool to improve the specificity of breast US in clinical practice, and as 
a guide in decision making for breast masses detected on US.  
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